TrialInternational journal of cancer2021

Randomized clinical trial of pembrolizumab vs chemotherapy for previously untreated Chinese patients with PD-L1-positive locally advanced or metastatic non-small-cell lung cancer: KEYNOTE-042 China Study.

Yi-Long Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.